CT, magnetic resonance imaging, and SPECT iodine-123 iodoamphetamine imaging of a patient with progressive cognitive deterioration. Clin Nucl Med 1987 Jun;12(6):463-5
Date
06/01/1987Pubmed ID
3496185DOI
10.1097/00003072-198706000-00013Scopus ID
2-s2.0-0023265814 (requires institutional sign-in at Scopus site)Abstract
A case of progressive cognitive deterioration is presented in which I-123 iodoamphetamine SPECT brain imaging was of value in confirming the clinical diagnosis of Alzheimer's disease.
Author List
Tikofsky RS, Harsch HH, Goldstein MD, Collier BD, Hellman RSAuthors
Harold H. Harsch MD Professor in the Psychiatry and Behavioral Medicine department at Medical College of WisconsinRobert Hellman MD Emeritus Professor in the Radiology department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
AgedAlzheimer Disease
Amphetamines
Brain
Female
Humans
Iodine Radioisotopes
Magnetic Resonance Spectroscopy
Tomography, Emission-Computed
Tomography, X-Ray Computed
